| 8334343 | Composite, with 2 known prime factors. Cofactor is composite. Trial Factored to 268 TF target 268 |
| Factored | |
| P-1 factors | |
| PRP Cofactor | | Status | Proof | Date | User | Residue | Number of
known factors | Shift | Type | Base |
|---|
| Factored | PRP without proof (not generated) | 2018-10-18 | Oliver Kruse | 1C7778C16BB6981D | 1 | 8232611 | 5 | 3 | | Factored | PRP without proof (not generated) | 2020-04-23 | Igvan28 | 1C7778C16BB6981D | 1 | 2957087 | 5 | 3 | | Verified | Certified Good | 2024-05-16 | dnova | 1C7778C16BB6981D | 2 | 2264802 | 5 | 3 |
|
| History | | Date | User | Type | Result |
|---|
| 2024-05-16 | S00030 | CERT | Proof certified good | | 2024-05-16 | dnova | C-PRP | M8334343/83343431/16941389676641937644658481 : 1C7778C16BB6981D Proof Certified Good
Proof Power: 8
| | 2024-05-10 | Stef42 | F-PM1 | Factor: 16941389676641937644658481 / B1=1025000, B2=1519818300 | | 2020-04-23 | Igvan28 | C-PRP | M8334343/83343431 : 1C7778C16BB6981D | | 2018-10-18 | Oliver Kruse | C-PRP | M8334343/83343431 : 1C7778C16BB6981D |
|
